HUTCHMED (China) Limited (HCM) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 8 Buy, 1 Hold, 1 Sell.
The consensus price target is $17.50, representing an upside of 15.1% from the current price $15.21.
Analysts estimate Earnings Per Share (EPS) of $0.00 and revenue of $0.09B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.20 vs est $0.00 (beat +5764.6%). 2025: actual $2.65 vs est $0.34 (beat +672.1%). Analyst accuracy: 6%.
HCM Stock — 12-Month Price Forecast
$17.50
▲ +15.06% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for HUTCHMED (China) Limited, the price target is $17.50.
The average price target represents a +15.06% change from the last price of $15.21.
HCM Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to HUTCHMED (China) Limited in the past 3 months
EPS Estimates — HCM
6%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.20
vs Est –$0.00
▲ 101.8% off
2025
Actual $2.65
vs Est $0.34
▲ 87.0% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — HCM
13%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.630B
vs Est $0.085B
▲ 86.5% off
2025
Actual $0.550B
vs Est $0.072B
▲ 86.9% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
